Early detection of apoptosis and Fas ligand expression in hepatic graft- versus-host disease after rat small bowel transplantation

Journal of Surgical Research

Volumn 86, Issue 1, 1999, Pages 136-144

  Shiraishi, Masayuki ^a   Hiroyasu, Shungo ^a   Oshiro, Takashi ^a   Nagahama, Masayoshi ^a   Tomori, Hirofumi ^a   Mamadi, Toure ^a   Muto, Yoshihiro ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Apoptosis; Fas; Fas ligand

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FAS ANTIGEN; FAS LIGAND; MESSENGER RNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; GRAFT VERSUS HOST REACTION; INTESTINE TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032846511     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1999.5706     Document Type: Article

References (31)

1. Clark C. L., Price B. A., Malcolm P., Lear P. A., Wood R. F. Graft versus host disease in small bowel transplantation. Br. J. Surg. 78:1991;1077.
2. Lefrancois L. Phenotypic complexity of intraepithelial lymphocytes of the small intestine. J. Immunol. 147:1991;1746.
3. Blazar B. R., Taylor P. A., Panoskaltsis-Mortari A., Barrett T. A., Bluestone J. A., Vallera D. A. Lethal murine graft-versus-host disease induced by donor gamma/delta expressing T cells with specificity for host nonclassical major histocompatibility complex class Ib antigens. Blood. 87:1996;827.
4. Via C. S., Nguyen P., Shustov A., Drappa J., Elkon K. B. A major role for the Fas pathway in acute graft-versus-host disease. J. Immunol. 157:1996;5387.
5. Braun M. Y., Lowin B., French L., Acha Orbea H., Tschopp J. Cytotoxic T cells deficient in both functional Fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J. Exp. Med. 183:1996;657.
6. Baker M. B., Altman N. H., Podack E. R., Levy R. B. The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice. J. Exp. Med. 183:1996;2645.
7. Sakai T., Kimura Y., Inagaki-Ohara K., Kusugami K., Lynch D. H., Yoshikai Y. Fas-mediated cytotoxicity by intestinal intraepithelial lymphocytes during acute graft-versus-host disease in mice. Gastroenterology. 113:1997;168.
8. Galle P. R., Hofmann W. J., Walczak H., Schaller H., Otto G., Stremmel W., Krammer P. H., Runkel L. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J. Exp. Med. 182:1995;1223.
9. Ogasawara J., Watanabe-Fukunaga R., Adachi M., Matsuzawa A., Kasugai T., Kitamura Y., Itoh N., Suda T., Nagata S. Lethal effect of the anti-Fas antibody in mice. Nature. 364:1993;806.
10. Monchik G. J., Russell P. S. Transplantation of small bowel in the rat: Technical and immunological considerations. Surgery. 70:1971;693.
11. Gavrieli Y., Sherman Y., Ben Sasson S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:1992;493.
12. Adams J. C. Heavy metal intensification of DAB-based HRP reaction product [letter]. J. Histochem. Cytochem. 29:1981;775.
13. Hakuno N., Koji T., Yano T., Kobayashi N., Tsutsumi O., Taketani Y., Nakane P. K. Fas/APO-1/CD95 system as a mediator of granulosa cell apoptosis in ovarian follicle atresia. Endocrinology. 137:1996;1938.
14. Oehm A., Behrmann I., Falk W., Pawlita M., Maier G., Klas C., Li, Weber M., Richards S., Dhein J., Trauth B. C., Ponstingl H., Krammer P. H. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily: Sequence identity with the Fas antigen. J. Biol. Chem. 267:1992;10709-10715.
15. Suda T., Takahashi T., Golstein P., Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 75:1993;1169.
16. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156.
17. Kimura K., Wakatsuki T., Yamamoto M. A variant mRNA species encoding a truncated form of Fas antigen in the rat liver. Biochem. Biophys. Res. Commun. 198:1994;666.
18. Tilly J. L., Tilly K. I., Kenton M. L., Johnson A. L. Expression of members of the bcl-2 gene family in the immature rat ovary: Equine chorionic gonadotropin-mediated inhibition of granulosa cell apoptosis is associated with decreased bax and constitutive bcl-2 and bcl-xlong messenger ribonucleic acid levels. Endocrinology. 136:1995;232.
19. Madison D. L., Pfeiffer S. E. Cloning of the 3′ end of rat bax-alpha and corresponding developmental down-regulation in differentiating primary, cultured oligodendrocytes. Neurosci. Lett. 220:1996;183.
20. Sato T., Irie S., Krajewski S., Reed J. C. Cloning and sequencing of a cDNA encoding the rat Bcl-2 protein. Gene. 140:1994;291.
21. Higashitsuji H., Arii S., Furutani M., Mise M., Monden K., Fujita S., Ishiguro S., Kitao T., Nakamura T., Nakayama H., Fujita J., Imamura M. Expression of cytokine genes during liver regeneration after partial hepatectomy in rats. J. Surg. Res. 58:1995;267.
22. Nudel U., Zakut R., Shani M., Neuman S., Levy Z., Yaffe D. The nucleotide sequence of the rat cytoplasmic beta-actin gene. Nucleic Acids Res. 11:1983;1759.
23. Yokoi H., Natsuyama S., Iwai M., Noda Y., Mori T., Mori K. J., Fujita K., Nakayama H., Fujita J. Non-radioisotopic quantitative RT-PCR to detect changes in mRNA levels during early mouse embryo development. Biochem. Biophys. Res. Commun. 195:1993;769.
24. Deeg H. J., Storb R. Graft-versus-host disease: Pathophysiological and clinical aspects. Annu. Rev. Med. 35:1984;11.
25. Grant D., Zhong R., Gunn H., Duff J., Garcia B., Keown P., Wijsman J., Stiller C. Graft-versus-host disease associated with intestinal transplantation in the rat: Host immune function and general histology. Transplantation. 48:1989;545.
26. Nogae S., Miyazaki M., Kobayashi N., Saito T., Abe K., Saito H., Nakane P. K., Nakanishi Y., Koji T. Induction of apoptosis in ischemia-reperfusion model of mouse kidney: Possible involvement of Fas. J. Am. Soc. Nephrol. 9:1998;620.
27. Krams S. M., Martinez O. M. Apoptosis as a mechanism of tissue injury in liver allograft rejection. Semin. Liver Dis. 18:1998;153.
28. Miglio F., Pignatelli M., Mazzeo V., Baraldini M., Stefanini G. F., Guardigli G., Bandini G., Ricci P., Tura S., Gasbarrini G. Expression of major histocompatibility complex class II antigens on bile duct epithelium in patients with hepatic graft-versus-host disease after bone marrow transplantation. J. Hepatol. 5:1987;182.
29. Suda T., Okazaki T., Naito Y., Yokota T., Arai N., Ozaki S., Nakao K., Nagata S. Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 154:1995;3806.
30. Muller M., Strand S., Hug H., Heinemann E. M., Walczak H., Hofmann W. J., Stremmel W., Krammer P. H., Galle P. R. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J. Clin. Invest. 99:1997;403.
31. Schelling J. R., Nkemere N., Kopp J. B., Cleveland R. P. Fas-dependent fratricidal apoptosis is a mechanism of tubular epithelial cell deletion in chronic renal failure. Lab. Invest. 78:1998;813.